Pancreatic Cancer Research

ResearcherAnhui Medical UniversityActive in the last 2 years

Kuiwu Ren

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5103977172. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Deubiquitinase OTUD4 Stabilizes SLC5A2 to Promote Pancreatic Cancer Proliferation and Migration Through Enchaining Glycolysis-Mediated Autophagy. Co-author DOI 10.1096/fj.202501018r↗
  2. The close association of Muribaculum and PA (10:0/a-17:0) with the occurrence of pancreatic ductal adenocarcinoma and immunotherapy. First author DOI 10.3389/fimmu.2024.1505966↗
  3. Pancreatic Cancer and its Attributable Risk Factors in East Asia, Now and Future. Co-author DOI 10.1093/oncolo/oyad147↗
  4. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma. Last author DOI 10.3389/fonc.2021.711402↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiangtao Yu · 3 shared papers, 2023–2025 · strength 0.62
  2. Chunlong Liu · 2 shared papers, 2023–2024 · strength 0.37
  3. Panpan Wu · 2 shared papers, 2023–2024 · strength 0.37
  4. Fengrui Wu · 1 shared paper, 2025 · strength 0.26
  5. Xin Xie · 1 shared paper, 2025 · strength 0.26
  6. Edward Wang · 1 shared paper, 2024 · strength 0.20
  7. Kun Song · 1 shared paper, 2024 · strength 0.20
  8. Jian Zhang · 1 shared paper, 2023 · strength 0.17
  9. Jiacheng Huang · 1 shared paper, 2021 · strength 0.16
  10. Zhitao Chen · 1 shared paper, 2021 · strength 0.16
  11. Shengzhang Lin · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.